Małgorzata Szeląg

803 total citations
20 papers, 655 citations indexed

About

Małgorzata Szeląg is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Małgorzata Szeląg has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Małgorzata Szeląg's work include Free Radicals and Antioxidants (7 papers), Cytokine Signaling Pathways and Interactions (7 papers) and interferon and immune responses (3 papers). Małgorzata Szeląg is often cited by papers focused on Free Radicals and Antioxidants (7 papers), Cytokine Signaling Pathways and Interactions (7 papers) and interferon and immune responses (3 papers). Małgorzata Szeląg collaborates with scholars based in Poland, France and Netherlands. Małgorzata Szeląg's co-authors include Marcin Molski, Alicja Urbaniak, Hans A.R. Bluyssen, Joanna Wesoły, Damian Mikulski, Anna Czerwoniec, Ewa D. Raczyńska, Tomasz Wrzesiński, Zbigniew Kwias and Rachel H. Giles and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Małgorzata Szeląg

20 papers receiving 647 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Małgorzata Szeląg 233 181 109 92 83 20 655
Donald F. Stec 211 0.9× 575 3.2× 60 0.6× 69 0.8× 31 0.4× 49 1.2k
Seung Wook Ham 317 1.4× 523 2.9× 21 0.2× 75 0.8× 79 1.0× 57 1.0k
Martin Štícha 396 1.7× 546 3.0× 229 2.1× 56 0.6× 25 0.3× 69 1.2k
Diane Rindgen 247 1.1× 405 2.2× 89 0.8× 137 1.5× 119 1.4× 24 894
Alain Barbin 158 0.7× 859 4.7× 74 0.7× 151 1.6× 27 0.3× 28 1.5k
Fernando Villena 87 0.4× 334 1.8× 49 0.4× 34 0.4× 18 0.2× 33 648
Gregory M. Raner 60 0.3× 351 1.9× 46 0.4× 157 1.7× 19 0.2× 33 859
Mark C. Walker 354 1.5× 473 2.6× 12 0.1× 41 0.4× 52 0.6× 32 1.2k
A. Petkau 185 0.8× 685 3.8× 71 0.7× 55 0.6× 42 0.5× 54 1.3k
N. J. de Mol 221 0.9× 326 1.8× 40 0.4× 34 0.4× 22 0.3× 30 656

Countries citing papers authored by Małgorzata Szeląg

Since Specialization
Citations

This map shows the geographic impact of Małgorzata Szeląg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Szeląg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Szeląg more than expected).

Fields of papers citing papers by Małgorzata Szeląg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Szeląg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Szeląg. The network helps show where Małgorzata Szeląg may publish in the future.

Co-authorship network of co-authors of Małgorzata Szeląg

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Szeląg. A scholar is included among the top collaborators of Małgorzata Szeląg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Szeląg. Małgorzata Szeląg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szeląg, Małgorzata, Aida Collado, Patrice Marqués, et al.. (2018). Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs. Frontiers in Immunology. 9. 2141–2141. 12 indexed citations
2.
Urbaniak, Alicja, et al.. (2017). Antioxidant properties of several caffeic acid derivatives: A theoretical study. Comptes Rendus Chimie. 20(11-12). 1072–1082. 25 indexed citations
3.
Szeląg, Małgorzata, Joanna Wesoły, & Hans A.R. Bluyssen. (2016). Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases. Current Protein and Peptide Science. 17(2). 135–146. 10 indexed citations
4.
Szeląg, Małgorzata, et al.. (2016). Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease. Oncotarget. 7(30). 48788–48812. 53 indexed citations
5.
Szeląg, Małgorzata, Anna Czerwoniec, Joanna Wesoły, & Hans A.R. Bluyssen. (2015). Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation. PLoS ONE. 10(2). e0116688–e0116688. 30 indexed citations
6.
Wrzesiński, Tomasz, Małgorzata Szeląg, Rachel H. Giles, et al.. (2015). Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. BMC Cancer. 15(1). 518–518. 83 indexed citations
7.
Czerwoniec, Anna, Małgorzata Szeląg, Kajetan Juszczak, Joanna Wesoły, & Hans A.R. Bluyssen. (2015). CAVS—Novel in silico selection strategy of specific STAT inhibitory compounds. Journal of Computational Science. 10. 186–194. 6 indexed citations
8.
Szeląg, Małgorzata, Anna Czerwoniec, Joanna Wesoły, & Hans A.R. Bluyssen. (2014). Comparative screening and validation as a novel tool to identify STAT-specific inhibitors. European Journal of Pharmacology. 740. 417–420. 8 indexed citations
9.
Szeląg, Małgorzata, Alicja Urbaniak, & Hans A.R. Bluyssen. (2014). A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids. Open Chemistry. 13(1). 38 indexed citations
10.
Szeląg, Małgorzata, et al.. (2014). Low-molecular weight organic acids and peptides involved in the long-distance transport of trace metals. Acta Physiologiae Plantarum. 36(8). 1957–1968. 64 indexed citations
11.
Szeląg, Małgorzata, et al.. (2013). In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity. European Journal of Pharmacology. 720(1-3). 38–48. 26 indexed citations
12.
Urbaniak, Alicja, Małgorzata Szeląg, & Marcin Molski. (2013). Theoretical investigation of stereochemistry and solvent influence on antioxidant activity of ferulic acid. Computational and Theoretical Chemistry. 1012. 33–40. 82 indexed citations
13.
Urbaniak, Alicja, Marcin Molski, & Małgorzata Szeląg. (2012). Quantum-chemical Calculations of the Antioxidant Properties of trans-p-coumaric Acid and trans-sinapinic Acid. Computational Methods in Science and Technology. 18(2). 117–128. 42 indexed citations
14.
Mikulski, Damian, Małgorzata Szeląg, & Marcin Molski. (2011). Quantum-chemical study of interactions of trans-resveratrol with guanine-thymine dinucleotide and DNA-nucleobases. Journal of Molecular Modeling. 17(12). 3085–3102. 2 indexed citations
15.
Szeląg, Małgorzata, Damian Mikulski, & Marcin Molski. (2011). Quantum-chemical investigation of the structure and the antioxidant properties of α-lipoic acid and its metabolites. Journal of Molecular Modeling. 18(7). 2907–2916. 79 indexed citations
16.
Mikulski, Damian, et al.. (2010). Quantum-chemical study on the antioxidation mechanisms of trans-resveratrol reactions with free radicals in the gas phase, water and ethanol environment. Journal of Molecular Structure THEOCHEM. 951(1-3). 37–48. 34 indexed citations
17.
Raczyńska, Ewa D., et al.. (2010). Importance of CH tautomers in the tautomeric mixture of uric acid. Journal of Molecular Structure THEOCHEM. 947(1-3). 83–91. 13 indexed citations
18.
Raczyńska, Ewa D., Jean‐François Gal, Pierre‐Charles Maria, & Małgorzata Szeląg. (2009). Proton Transfer Chemistry in the Gas Phase. Is a Spontaneous 'Neutralization' Reaction a Myth or a Reality?. Croatica Chemica Acta. 82(1). 87–103. 16 indexed citations
19.
Wierzchowski, Jacek, Monika Pietrzak, Małgorzata Szeląg, & Piotr Wroczyński. (2007). Salivary aldehyde dehydrogenase—Reversible oxidation of the enzyme and its inhibition by caffeine, investigated using fluorimetric method. Archives of Oral Biology. 53(5). 423–428. 14 indexed citations
20.
Raczyńska, Ewa D., J.‐F. Gal, Pierre‐Charles Maria, Katarzyna Zientara‐Rytter, & Małgorzata Szeląg. (2007). Application of FT-ICR-MS for the study of proton-transfer reactions involving biomolecules. Analytical and Bioanalytical Chemistry. 389(5). 1365–1380. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald F. Stec Breakdown of academic impact, for papers by Seung Wook Ham Breakdown of academic impact, for papers by Martin Štícha Breakdown of academic impact, for papers by Diane Rindgen Breakdown of academic impact, for papers by Alain Barbin Breakdown of academic impact, for papers by Fernando Villena Breakdown of academic impact, for papers by Gregory M. Raner Breakdown of academic impact, for papers by Mark C. Walker Breakdown of academic impact, for papers by A. Petkau Breakdown of academic impact, for papers by N. J. de Mol
Rankless by CCL
2026